SLDB

2.90

5.07% 0.14

Dopo l'orario di chiusura: 2.91 0.01 +0.34%

Solid Biosciences Inc (SLDB)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché SLDB Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$2.76

Aprire:

$2.89

Volume 24 ore:

1.44M

Relative Volume:

0.54

Capitalizzazione di mercato:

$327.83M

Reddito:

$14.79M

Utile/perdita netta:

$-102.44M

Rapporto P/E:

-0.9539

EPS:

-3.04

Flusso di cassa netto:

$-91.73M

1 W Prestazione:

-31.44%

1M Prestazione:

+7.41%

6M Prestazione:

-47.37%

1 anno Prestazione:

-72.09%

Intervallo 1D:

$2.76

$3.005

Intervallo di 1 settimana:

$2.52

$4.189

Portata 52W:

$2.45

$10.68

Solid Biosciences Inc Stock (SLDB) Company Profile

Nome

Solid Biosciences Inc

Settore

Healthcare (1181)

Industria

Biotechnology (676)

Telefono

617-337-4680

Indirizzo

500 RUTHERFORD AVENUE, CHARLESTOWN, MA

Dipendente

100

Cinguettio

@SolidBioDMD

Prossima data di guadagno

2024-11-06

Ultimi documenti SEC

SLDB's Discussions on Twitter

Confronta SLDB con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SLDB Solid Biosciences Inc	2.90	327.83M	14.79M	-102.44M	-91.73M	-3.04
VRTX Vertex Pharmaceuticals Inc	439.37	128.45B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	575.63	65.17B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	560.90	40.09B	2.58B	1.06B	-1.28B	16.33
ALNY Alnylam Pharmaceuticals Inc	270.19	35.67B	2.35B	-269.70M	-75.39M	-2.09
ONC Beigene Ltd Adr	233.25	27.44B	3.81B	-644.79M	-669.77M	-6.24

Solid Biosciences Inc Stock (SLDB) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-01-08	Iniziato	Truist	Buy
2024-12-13	Iniziato	Wedbush	Outperform
2024-12-10	Iniziato	JMP Securities	Mkt Outperform
2024-07-15	Aggiornamento	JP Morgan	Neutral → Overweight
2024-06-24	Aggiornamento	Leerink Partners	Market Perform → Outperform
2024-05-31	Ripresa	Piper Sandler	Overweight
2024-03-28	Iniziato	William Blair	Outperform
2024-03-15	Iniziato	Citigroup	Buy
2024-03-14	Aggiornamento	Piper Sandler	Neutral → Overweight
2023-12-08	Iniziato	H.C. Wainwright	Buy
2021-07-12	Iniziato	Piper Sandler	Neutral
2021-05-27	Iniziato	Jefferies	Buy
2021-03-16	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2021-03-09	Iniziato	Barclays	Overweight
2021-01-08	Aggiornamento	Credit Suisse	Underperform → Neutral
2020-07-28	Downgrade	SVB Leerink	Outperform → Mkt Perform
2020-05-07	Downgrade	Evercore ISI	Outperform → In-line
2019-10-11	Iniziato	Evercore ISI	Outperform
2019-08-29	Downgrade	Citigroup	Neutral → Sell
2019-08-19	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2019-08-16	Aggiornamento	Chardan Capital Markets	Neutral → Buy
2019-05-14	Downgrade	Credit Suisse	Neutral → Underperform
2019-05-14	Downgrade	Goldman	Neutral → Sell
2019-02-08	Aggiornamento	Citigroup	Sell → Neutral
2019-02-08	Downgrade	SVB Leerink	Outperform → Mkt Perform
2018-11-06	Iniziato	Citigroup	Sell
2018-09-06	Iniziato	Credit Suisse	Neutral

Mostra tutto

Solid Biosciences Inc Borsa (SLDB) Ultime notizie

May 01, 2025

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 01, 2025

Solid Biosciences Expands Team: 81,000 RSUs Awarded to 7 Strategic New Hires - Stock Titan

May 01, 2025

Apr 30, 2025

Solid Biosciences to Participate at The Citizens Life Sciences Conference - The Manila Times

Apr 30, 2025

Exclusive: Solid Biosciences CEO Ready to Reveal Latest Company Vision at Major Life Sciences Event - Stock Titan

Apr 30, 2025

Apr 29, 2025

Solid Biosciences to Present at the American Society of Gene and Cell Therapy's 28th Annual Meeting - The Manila Times

Apr 29, 2025

Solid Biosciences to Present Phase 1/2 Trial Data for SGT-003 Gene Therapy at ASGCT 2025 Annual Meeting - Nasdaq

Apr 29, 2025

Solid Biosciences to Present at the American Society of Gene and Cell Therapy’s 28th Annual Meeting - GlobeNewswire

Apr 29, 2025

New Duchenne Treatment Breakthrough: Solid Bio Unveils Critical Gene Therapy Trial Results at Major Conference - Stock Titan

Apr 29, 2025

Apr 28, 2025

Montai Therapeutics Appoints Allison Bogosian, JD, as Chief People and Administrative Officer - Business Wire

Apr 28, 2025

Apr 21, 2025

Piper Sandler Remains a Buy on Solid Biosciences (SLDB) - The Globe and Mail

Apr 21, 2025

Apr 19, 2025

Certain Restricted Stock Units of Solid Biosciences Inc. are subject to a Lock-Up Agreement Ending on 20-APR-2025. - marketscreener.com

Apr 19, 2025

Certain Common Stock of Solid Biosciences Inc. are subject to a Lock-Up Agreement Ending on 20-APR-2025. - marketscreener.com

Apr 19, 2025

Apr 16, 2025

Solid Biosciences stock hits 52-week low at $2.47 By Investing.com - Investing.com South Africa

Apr 16, 2025

Solid Biosciences stock hits 52-week low at $2.47 - Investing.com Australia

Apr 16, 2025

Apr 13, 2025

Can Solid Biosciences Challenge Sarepta in the DMD Market? - MSN

Apr 13, 2025

Apr 08, 2025

Solid Biosciences: A Strong Buy As An Emerging Biotech In The Gene Therapy Space - Seeking Alpha

Apr 08, 2025

Apr 07, 2025

Solid Biosciences stock hits 52-week low at $2.88 - Investing.com Australia

Apr 07, 2025

Solid Biosciences stock hits 52-week low at $2.88 By Investing.com - Investing.com South Africa

Apr 07, 2025

Solid Biosciences to Participate at Upcoming Investor Conferences - GlobeNewswire

Apr 07, 2025

Exclusive Access: Solid Biosciences Leadership Team Headlines Two Major Healthcare Conferences - Stock Titan

Apr 07, 2025

Apr 01, 2025

Solid Biosciences reports inducement grants under Nasdaq listing rule - TipRanks

Apr 01, 2025

Solid Biosciences Expands Team with 43,374 RSU Grants in Strategic Hiring Move - Stock Titan

Apr 01, 2025

Mar 20, 2025

Sarepta safety update on Elevidys boosts Regenxbio, hurts Solid Bio - MSN

Mar 20, 2025

Truist Financial Keeps Their Buy Rating on Solid Biosciences (SLDB) - The Globe and Mail

Mar 20, 2025

Mar 19, 2025

Solid Biosciences Inc.'s (NASDAQ:SLDB) market cap dropped US$53m last week; Private equity firms bore the brunt - simplywall.st

Mar 19, 2025

Mar 18, 2025

Regenxbio stock up, Solid Bio down post Sarepta update (RGNX) - Seeking Alpha

Mar 18, 2025

Mar 14, 2025